Melissa Corcoran, M.D.
Hematology & Oncology Physician in Burlington, North Carolina.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Melissa Corcoran, M.D. reported a CMS MIPS final score of 95.4/100 - above the 83.5 national average - and filed 647 Medicare Part D claims in 2023.
- 95.4/100
- MIPS score · +12 vs avg
- 647
- Part D claims, 2023
- 84%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1114976032 · Hematology & Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-ELITE · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1114976032
- ENUM-LEGACY 2006
- TAX-MID 11K Hematology &
- MIPS-ELITE 95.4/100
- RX-LIGHT 647
- BOOK-THIN 351 in North Carolina
- PHOTO-FINISH Michael Tulloch · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Alejandra Perez …
Alejandra Perez
95.3 MIPS pts
- Corcoran · this …
Corcoran · this provider
95.4 MIPS pts
- Kinan Yarta · hi…
Kinan Yarta
95.4 MIPS pts
- Haroutioun Shahi…
Haroutioun Shahinian
95.4 MIPS pts
- Michael Tulloch …
Michael Tulloch
95.4 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Melissa Corcoran, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
95 ≥ 78th percentile 78% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Melissa Corcoran, M.D. sits
This provider among hematology & oncology physician peers
Across the 4,019 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Melissa Corcoran, M.D. writes more Part D claims than 46% of them and scores higher on MIPS quality than 76% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Melissa Corcoran, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Melissa Corcoran, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Melissa Corcoran, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in North Carolina
How Hematology & Oncology Physician compares to other specialties among North Carolina providers
Hematology & Oncology Physician ranks #67 among North Carolina's specialties (0.2% of in-state providers)
Each bar is a specialty's share of the North Carolina provider total, by primary NUCC taxonomy. The highlighted bar is Hematology & Oncology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Melissa Corcoran, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 95.4/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Specialty volume Hematology & Oncology Physician US NPIs
95.4/100 MIPS final score - 11.9 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Hematology & Oncology Physician. Quality dim: 84.2.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1114976032 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 05/08/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Melissa Corcoran, M.D.'s current license status, disciplinary history, and board certifications with the North Carolina Medical Board in North Carolina before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1114976032 is the unique 10-digit identifier CMS uses to link Corcoran across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Melissa Corcoran, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$104
Largest payer
Merck Sharp & Dohme LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
16% brand-name claims vs 84% generic, on 647 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 796
- Total Day Supply
- 19,986
- Brand vs Generic
- 16% brand / 84% generic
- Brand Drug Cost
- $1.2M
- Generic Drug Cost
- $385K
- Opioid Claims
- 99 (15.3% rate)
- Antibiotic Claims
- 16
Patient Demographics
- Average Patient Age
- 73.6 years
- Avg HCC Risk Score
- 2.46
- Gender Split
- 65% female / 35% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Melissa Corcoran, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Dexamethasone
Dexamethasone
44 claims
- Letrozole
Letrozole
44 claims
- Ondansetron Hcl
Ondansetron Hcl
42 claims
- Potassium Chloride
Potassium Chloride
35 claims
- Oxycodone Hcl
Oxycodone Hcl
34 claims
- Revlimid
Revlimid
33 claims
- Prochlorperazine M…
Prochlorperazine Maleate
22 claims
- Ibrance
Ibrance
20 claims
| Drug | Claims |
|---|---|
| Dexamethasone | 44 |
| Letrozole | 44 |
| Ondansetron Hcl | 42 |
| Potassium Chloride | 35 |
| Oxycodone Hcl | 34 |
| Revlimid Lenalidomide | 33 |
| Prochlorperazine Maleate | 22 |
| Ibrance Palbociclib | 20 |
| Lenalidomide | 20 |
| Omeprazole | 20 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Melissa Corcoran, M.D. fits within the Hematology & Oncology Physician landscape nationally.
Melissa Corcoran, M.D.'s 647 claims are below the specialty average of 847.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Corcoran, both outside North Carolina so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (95.4 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in North Carolina
Other clinicians with the same primary specialty enrolled in North Carolina, drawn from the same CMS NPPES roster as Corcoran.
One of 351 Hematology & Oncology Physician providers enrolled in North Carolina, 5 are shown here.
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Melissa Corcoran, M.D.'s specialty? ▼
How much does Melissa Corcoran, M.D. prescribe under Medicare Part D? ▼
What is Melissa Corcoran, M.D.'s Medicare quality score? ▼
Where is Melissa Corcoran, M.D. located? ▼
What is Melissa Corcoran, M.D.'s NPI number? ▼
Does Melissa Corcoran, M.D. prescribe more brand-name or generic drugs? ▼
Does Melissa Corcoran, M.D. prescribe opioids? ▼
How many Hematology & Oncology Physician providers are there in the US? ▼
What drugs does Melissa Corcoran, M.D. prescribe most often? ▼
Does Melissa Corcoran, M.D. accept Medicare? ▼
How can I verify Melissa Corcoran, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.